Application of 105191-12-6, In heterogeneous catalysis, the catalyst is in a different phase from the reactants. At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 105191-12-6, name is 6-Bromo-1H-indole-2-carbaldehyde. In an article£¬Which mentioned a new discovery about 105191-12-6
A DPP – 4 inhibitor and its preparation and use in diabetes (by machine translation)
The invention discloses a formula I indicated by the compound or its pharmaceutically acceptable salt Wherein R1 , R2 , R3 , R4 And R5 Independently selected from H or CF3 . In vitro DPP – 4 enzyme inhibition test of the compound included in the DPP – 4 of IC50 Indications less than omarigliptin and Sitagliptin. Indicates that the compound of the present invention has better DPP – 4 inhibitory activity, can be used as a medicine for treating and/or preventing non-insulin-dependent diabetes, high blood sugar or insulin-resistant pharmaceutical more deeper-level research. (by machine translation)
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.105191-12-6. In my other articles, you can also check out more blogs about 105191-12-6
Reference£º
Indole alkaloid derivatives as building blocks of natural products from?Bacillus thuringiensis?and?Bacillus velezensis?and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles